Overview

Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
Evaluation of the safety and tolerability of testosterone enanthate (TE) following a single dose via QuickShot® Testosterone (QST) 50 mg, 75 mg, or 100 mg when administered by intended users in a usability study.
Phase:
Phase 2
Details
Lead Sponsor:
Antares Pharma Inc.
Treatments:
Methyltestosterone
Testosterone
Testosterone 17 beta-cypionate
Testosterone enanthate
Testosterone undecanoate